| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |